@misc{indiciaebe1880ca510c,
  title = {Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity},
  author = {Teran Pumar, O. Y. and VanNoy, E. L. and Haffey, A. and Gannamedi, D. P. and Rafie, C. I. and Lykke Harwood, D. S. and Benedetti, J. R. and Pittman Ballard, C. A. and Ciervo, E. and Assenza Tavares Coroa, P. H. and Grover, P. and Leon, B. E. and Mitchell, J. and Pathak, A. and Colon, B. and El Ghorayeb, L. and O'Sullivan, L. and Venkatarame Gowda Saralamma, V. and Lopez Ruiz, C. and Khatwani, N. and Surinder, K. and Rai, P. and Schatz, J. and Shah, A. and Binder, Z. and Ceccarelli, M. and Ostrom, Q. T. and Kristensen, B. W. and Stelekati, E. and Watson, D. C. and Lombard, D. B. and Haydar, D. and Bayik, D.},
  year = {2026},
  doi = {10.64898/2026.03.31.715681},
  url = {https://www.biorxiv.org/content/10.64898/2026.03.31.715681v1},
  note = {Source identifier: 10.64898/2026.03.31.715681}
}